Introduction
The ketogenic diet, a high fat and low carbohydrate regimen, is effective for the treatment of intractable epilepsy. 1 Research suggests that the modified Atkins diet is similarly effective. 2, 3 Historically, the ketogenic diet is not always considered highly in the treatment option hierarchy, in part due to perceptions that children will find the high fat and low carbohydrate foods unpalatable. However, we found that children with seizures actually exhibit preferences for foods compatible with the ketogenic diet. 4 In our study, children with seizures exhibited higher preferences for high fat items and lower preferences for high carbohydrate items in comparison to children without seizures. 4 Children with seizures were observed to frequently choose items such as mayonnaise, butter, and cream cheese over high carbohydrate items such as candy and chips, often to the surprise of their parents. Clinicians and researchers have proposed that the ketogenic and modified Atkins diets be considered earlier in the course of the treatment of epilepsy, rather than as a ''last resort'', and have advocated for research to identify variables that might predict the best responders to these diets. 5 Research into EEG prediction factors have led to mixed results. 6, 7 Results from our previous study led us to question whether the extent of a child's fat preferences could also have predictive value. Dekker et al. 8 examined the preferences of 43 children and did not identify a significant correlation between fat preferences and ketogenic diet efficacy. However, these researchers utilized a
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retrospective, non-validated questionnaire completed by the children's parents (at times recollecting up to 5 years in the past) in addition to review of a parent-report food log completed prior to diet commencement, measuring consumption and not preference specifically. Given the noted inaccuracy of parent report of child food preferences, 4,9,10 as well as other methodological limitations of a retrospective study, Dekker et al. stated that further research should be prospective and should utilize methods that more closely correlate with a forced-choice paradigm.
To further explore fat preference as a potential predictor of efficacy of dietary therapy, a systematic forced-choice food preference assessment procedure was conducted with children with seizures who were about to start the ketogenic or modified Atkins diets and their subsequent response to the diets was assessed for the year following initiation. Although the preference assessment included both fat and carbohydrates, only fat preference was of interest, as dietary treatment involves increased consumption of such foods. It was hypothesized that strong preferences for high fat foods would be positively correlated with diet efficacy.
Materials and methods

Study population
A group of 33 children and adolescents with a history of seizures and who were scheduled to begin either the ketogenic or modified Atkins diets were recruited from the outpatient Pediatric Epilepsy clinic at the Johns Hopkins Hospital in Baltimore, MD. Prior to diet implementation, the study neurologist (EK) described the assessment procedure to parents and verbal agreement was obtained. Study research assistants then scheduled an appointment to obtain informed consent and assent, answer additional questions, and then implement assessment procedures immediately before or after the neurology visit. For children starting the traditional ketogenic diet, the testing was done on the morning of the admission during a 24-h fasting period (and hence in those cases, the fast was broken slightly by the small amount of foods). Starting the diet without a fasting period has been shown to still maintain long-term diet effectiveness. 11 For those starting the modified Atkins diet, the testing was done immediately following the 1-h outpatient clinic visit. These children were then initiated on the modified Atkins diet as recommended several days later. During recruitment, children with significant feeding problems (e.g., gastrostomy tube-fed or formula dependence), severe food allergies, adherence to special diets (e.g., vegetarian or kosher), or with prior use of the ketogenic or modified Atkins diets were excluded. After recruitment, one female child was disqualified from the study due to total noncompliance with study procedures; two others (one male and one female) did not participate secondary to family time constraints.
Of the 30 subjects who participated in the study, 15 started the ketogenic diet and 15 the modified Atkins diet. From the total group (15 males and 15 females), 12 were classified with partial and 18 with generalized epilepsy. Etiologies included: myoclonicastatic epilepsy (Doose syndrome) -9, childhood absence epilepsy -5, temporal lobe epilepsy -4, idiopathic partial -3, myoclonicabsence epilepsy -2, Sturge-Weber syndrome -2, Dravet syndrome -1, tuberous sclerosis complex -1, nodular heterotopias -1, encephalitis -1, and juvenile myoclonic epilepsy -1. The mean age for the total group at diet onset was 6.4 years (SEM = 0.65), and the mean seizure frequency at diet onset was 487 seizures per month (SEM = 16.4). There were no significant differences in seizure frequency at baseline between children in the ketogenic diet or modified Atkins diet subgroups.
Participants were recruited consecutively from among children who were being started on the ketogenic or modified Atkins diet at Johns Hopkins Hospital. This study was approved by the Kennedy Krieger Institute and Johns Hopkins Hospital Institutional Review Boards.
Food preference assessment procedure
In this prospective study, food preferences were directly evaluated via a paired choice assessment procedure as described by Fisher et al., 12 with behavioral definitions as originally described by Pace et al. 13 This applied behavior analysis method was refined for use with populations of varying degrees of cognitive disability, and has demonstrated good validity and reliability. 12, 14 The same standard group of 14 food items from the original study 4 was utilized. These items had been reviewed by a licensed dietician and chosen on the basis of their nutritional composition (i.e., high fat/low carbohydrate content versus high carbohydrate/ low fat content). 4 For both groups, attempts were made to represent both higher and lower intensity (e.g., bland) flavors, and to avoid brand-name and heavily advertised foods. 4 The seven high fat/low carbohydrate items consisted of butter, mayonnaise, American cheese, cream cheese, bacon, hot dogs, and bologna; the seven high carbohydrate/low fat items consisted of tortilla chip, candy corn, jelly bean, pretzel, potato, white bread, and noodles. They were presented in ''sample-size'' quantities (e.g., less than approximately one teaspoon or one bite) in 30 ml clear plastic cups. Foods that were required to be prepared according to the manufacturer's directions were served at the appropriate temperature. Identical to our previous study, 4 the food preference assessment consisted of a single 15-to 30-min session of repeated presentations, such that every food item was randomly paired with every other food item. Items were presented simultaneously, and the child was asked to choose (either by tasting, fully consuming, pointing, or verbally stating) one item from each pair. Choices were noted on pen and paper datasheets. The percentage of trials in which the child exhibited a positive choice response for each item was calculated by dividing the number of trials in which the item was chosen by the number of trials in which it was presented. As in the prior study, 4 an aggregate score for each food group (fat or carbohydrate) for each child was then obtained by summing those percentages for all items in each category (fat or carbohydrate). The highest possible score for a food group was 539 (i.e., if each of the 7 items in one food group was chosen for all paired trials in which it was presented).
Assessment of treatment efficacy
Efficacy of dietary therapy was determined via parental report of seizure frequency. Neurologists obtained reports, either during clinic visits or via phone communication, immediately prior to treatment (baseline) and at 1, 3, 6, and 12 months following initiation. Diet duration and additional medication changes were also documented. Diet efficacy was evaluated in terms of reduction from baseline seizure frequency and was categorized as seizure free (100%), 90-99%, 50-89%, or <50% reduction.
Scoring and data analyses
All analyses were done with 'SPSS for Windows', version 20.0. Diet efficacy raw scores were divided into the following categories: 1 = seizure free, 2 = 90-99% reduction, 3 = 50-89% reduction, and 4 = <50% reduction in seizures. We used intent-to-treat analysis. If a child stopped the diet, we entered their current outcomes (and used 0% improvement if they were lost to follow-up).
To explore the relationship between fat preference and diet efficacy, initial preference scores were correlated with diet efficacy at each time point (1, 3, 6, and 12 months). Additionally, overall efficacy was calculated for each participant according to the percentage of follow-ups at which they exhibited a specified level of seizure reduction. Correlations were conducted between initial fat preference scores and the percentage of follow-ups with 100% (seizure free), !90%, and !50% reduction.
As these data were nonparametric, Spearman's rho was used for all analyses. One-tailed Spearman rank-order correlations for fat preference scores and seizure control (diet efficacy) were conducted across the four time points of the observation and at the levels of efficacy previously specified. A p value of <.05 was considered significant for all analyses.
Results
Food preferences
As a group, children with seizures had an average aggregate fat preference score of 329.83 (SD = 92.27). This is very similar to previous study results in which children with epilepsy had an average score of 316.79 (SD = 82.55) compared to 265.03 (SD = 77.16) for those without seizures. 4 
Diet efficacy and duration
The number of children remaining on the diet and exhibiting seizure control at each level is displayed in Table 1 . At 1 month of dietary therapy, 23 of 30 participants had >50% seizure reduction, of which 8 were seizure free. At 3 months, 25 had >50% reduction, of which 9 were seizure free. At 6 and 12 months, 24 and 20 participants had >50% reduction, respectively, of which 10 at each time point were seizure free. There were not differences in efficacy between dietary therapies.
The majority of the patients had their diets adjusted after initiation (either increased fat or reduced carbohydrates typically) in order to try and improve efficacy. 15 Several patients became seizure free after having a less robust seizure reduction in the first 1-3 months. All children maintained at least moderate urinary ketosis on either diet. Intent-to-treat was used at each time point. At the 1-month time point, all 30 participants were still on the diet. At 3 months, 28 were still on the diet. At 6 and 12 months, 25 and 19, respectively, were still on the diet. Mean diet duration during the one-year follow-up was 9.6 months. Only one patient discontinued the diet due to intolerance (at 3 months); her fat preference score was 416, indicating a high fat preference. Diet duration was not correlated with fat preference (p = .424). Although results at individual time points were variable, more consistent effects were obtained when examining efficacy across the entire 12-month follow-up period. Fig. 2 depicts scatter plots of the percentage of participants' follow-ups at each criterion (100%, !90%, and !50% reduction) as a function of their fat preference score. The correlation between the percentage of seizure-free follow-ups and fat preference score was significant (r s [28] = .308, p = .048), as was the correlation with follow-ups with !90% reduction (r s [28] = .368, p = .023). Fat preference was not significantly correlated with percentage of checks with !50% reduction (r s [28] = .170, p = .183).
Relationship between preferences and treatment efficacy
Highest fat scores and efficacy
For the 10 participants with the highest fat preference scores (scores of 386 or above), 7 (70%) had !90% seizure reduction for 3 of the 4 follow-ups. Their individual data across time points are represented in Fig. 3 ; data for the 10 participants with the lowest fat preference scores are also provided.
Discussion
The purpose of this study was to examine whether preferences for high fat foods compatible with the ketogenic and modified Atkins diets were predictive of responsiveness to those diets in terms of seizure control among pediatric patients. Fat preference was directly assessed prior to commencing treatment and diet efficacy was assessed at four time points during a 1-year follow-up period.
The data from this prospective study provide some evidence to suggest that fat preference may be predictive of efficacy, but the results are far from conclusive. Modest correlations between fat preference and efficacy were observed at the 3, 6, and 12 months checks, but only the correlation at 3 months was significant, with correlations approaching significance at 6 and 12 months. It seems possible that power was reduced by the small size and heterogeneity of the sample, such that larger numbers would have allowed the significance noted at 3 months to persist, but that remains speculation at this point. Additionally, although the data were not significant at the 1-month follow-up, the correlation was much weaker than those observed at the other three checks. Perhaps the 1-month time period is too early to determine true ketogenic diet response. Furthermore, it is likely that there are still undetermined factors that may affect efficacy differentially across the duration of treatment. For instance, the possibility exists that fat preferences may change over the course of dietary therapy due to any number of reasons, ranging from the simple exposure to novel foods to the modification of biologic conditions that potentially established the original preferences via the diet. However, due to our design methodology, we did not re-assess preferences once the diet was started (i.e., could not expose them to the carbohydrate food items).
When exploring overall efficacy, more convincing data were found. Higher fat preference was moderately and significantly correlated with exhibiting the greatest degree of seizure control, 100% reduction, across the follow-up period. This relationship was slightly stronger when examining the percentage of follow-ups with !90% reduction. Interestingly, the correlation between fat preference and !50% reduction was weak and not significant. Taken together, these results suggest that the relationship between fat preference and efficacy may not be linear. That is, high fat preference may be predictive of high efficacy, but low fat preference may not be predictive of low efficacy (<50% reduction). As such, a cutoff may exist at which fat preference is most predictive of high efficacy. Determining if and where such a line should be drawn would be of particular clinical value. The individual data from this study suggest that a fat preference score near 400 may serve as this cutoff; however, future studies with larger sample sizes would be necessary to directly address this question. In addition, future research with larger samples could examine if there are differences in relative efficacy between the epileptic syndromes, etiology, or level of intellectual disability.
Although tentative, these results provide initial support for the predictive value of fat preference for responsiveness to dietary intervention. The modest correlations between fat preference and diet efficacy obtained in this study stand in contrast to the null findings of Dekker et al. 8 It seems likely that the difference in outcomes is a result of the methods used to assess preference. Further study utilizing direct measurement of preference is warranted. If these results are replicated and stronger associations are found, this would have important implications regarding use of a preference assessment as a possible screening tool for children being considered for ketogenic diet therapy, and future efforts could focus on ways to modify the assessment procedure to be more feasible to implement in a typical child neurology clinic.
Conclusion
This small prospective study found modest, positive correlations between fat preference and efficacy on the ketogenic and modified Atkins diets. Direct assessment of fat preference may be a useful screening tool for dietary therapy. High fat preference was correlated with !90% seizure reduction, but this relation may be nonlinear. Further research with larger participant samples is needed to more thoroughly evaluate this relationship, particularly with respect to any potential cutoff in fat preference score for predicting high efficacy 
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